Assessment of antidotal efficacy of cholinesterase reactivators against paraoxon: In vitro reactivation kinetics and physicochemical properties.

[1]  M. P. Kaushik,et al.  Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study. , 2014, Toxicology.

[2]  K. Kuča,et al.  In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes , 2014, Archives of Toxicology.

[3]  F. Worek,et al.  The value of novel oximes for treatment of poisoning by organophosphorus compounds. , 2013, Pharmacology & therapeutics.

[4]  F. Worek,et al.  Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase. , 2012, Toxicology letters.

[5]  P. Renard,et al.  Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. , 2012, Accounts of chemical research.

[6]  P. Taylor,et al.  Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases* , 2012, The Journal of Biological Chemistry.

[7]  Kibong Kim,et al.  Destruction and detection of chemical warfare agents. , 2011, Chemical reviews.

[8]  A. Srivastava,et al.  In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  D. Miron,et al.  Pharmacokinetics and pharmacodynamics of some oximes and associated therapeutic consequences: a critical review , 2010, Journal of applied toxicology : JAT.

[10]  K. Kuča,et al.  Passive diffusion of acetylcholinesterase oxime reactivators through the blood-brain barrier: influence of molecular structure. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  K. Kuča,et al.  In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase , 2009, Clinical toxicology.

[12]  M. Prostran,et al.  Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. , 2009, Current medicinal chemistry.

[13]  K. Kuča,et al.  Interactions of butane, but-2-ene or xylene-like linked bispyridinium para-aldoximes with native and tabun-inhibited human cholinesterases. , 2008, Chemico-biological interactions.

[14]  K. Kuča,et al.  Entry of two new asymmetric bispyridinium oximes (K‐27 and K‐48) into the rat brain: comparison with obidoxime , 2007, Journal of applied toxicology : JAT.

[15]  Kamil Kuca,et al.  Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. , 2007, Mini reviews in medicinal chemistry.

[16]  D. E. Clark,et al.  In Silico Predictions of Blood-Brain Barrier Penetration: Considerations to “Keep in Mind” , 2005, Journal of Pharmacology and Experimental Therapeutics.

[17]  H. Pajouhesh,et al.  Medicinal chemical properties of successful central nervous system drugs , 2005, NeuroRX.

[18]  K. Kuča,et al.  New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[19]  M. Yoshino,et al.  Pralidoxime Iodide (2-PAM) Penetrates Across the Blood-Brain Barrier , 2003, Neurochemical Research.

[20]  J. Goodwin,et al.  Physicochemical determinants of passive membrane permeability: role of solute hydrogen-bonding potential and volume. , 2001, Journal of medicinal chemistry.

[21]  F. Lombardo,et al.  ElogPoct: a tool for lipophilicity determination in drug discovery. , 2000, Journal of medicinal chemistry.

[22]  P. Eyer,et al.  Improved determination of acetylcholinesterase activity in human whole blood. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[23]  K. Kuča,et al.  In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties. , 2010, Chemical research in toxicology.

[24]  R. Kaliszan,et al.  Simultaneous determination of pKa and lipophilicity by gradient RP HPLC. , 2006, Analytical chemistry.

[25]  David E. Clark,et al.  Chapter 10 Computational Prediction of ADMET Properties: Recent Developments and Future Challenges , 2005 .

[26]  B. Foretić,et al.  The Dissociation Constants of 1,1′-Bis (pyridinium-4-aldoxime)trimethylene dibromide , 2004 .